BCIQ Profiles

Company Profile Report
0428 Adcentrx ECP EMB wed 5pm PT
BioCentury & Getty Images

Emerging Company Profile

Adcentrx: new linker-payload combos for improved ADC therapeutic windows

Emerging Company Profile: Adcentrx debuts to develop ADCs using new linkers, drugs to improve safety, efficacy

Adcentrx emerges with CBC-led $50 million A round to develop ADCs with optimized antibody-drug-linker combinations for improved safety and efficacy.

Apr 29, 2021 | 2:02 AM GMT

Read the full 610 word article

How to gain access

Continue reading with a
two-week free trial.